+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Acute Respiratory Disease Diagnostics Market Size, Share & Trends Analysis Report by Test, Pathogen, End-use and Region with Growth Forecasts, 2025-2033

  • PDF Icon

    Report

  • 150 Pages
  • November 2025
  • Region: Global
  • Grand View Research
  • ID: 6214455
REQUEST CUSTOMIZATION
Description Jump to:
The global acute respiratory disease diagnostics market size was estimated at USD 5.49 billion in 2024 and is projected to reach USD 10.71 billion by 2033, growing at a CAGR of 7.01% from 2025 to 2033. Some of the major factors driving the market are rising disease burden of respiratory conditions, advancements in diagnostic technologies, and increasing demand for early detection & decentralized testing.

According to the Institute for Health Metrics and Evaluation (IHME) in April 2023, chronic respiratory diseases (CRDs) are the third leading cause of death globally. Furthermore, the market growth is driven by the ageing demographic shift, increased healthcare infrastructure & investment in developing markets, government initiatives, public health programs & funding. The rise in the proportion of older people globally has led to an increase in cases of respiratory disorders, as older age is often associated with decreased lung capacity and decreased immune functioning. This demographic shift introduces significant risk for the development of chronic and acute infections with co-morbidities, including pneumonia, chronic obstructive pulmonary disease (COPD), and influenza. As a result, there is an increasing demand for rapid and accurate diagnostic tools for early detection, timely intervention, and improved clinical outcomes among the aging demographic.

Simultaneously, the healthcare infrastructure in emerging economies is rapidly expanding, providing a solid base for the adoption of new diagnostic techniques. Countries in the Asia-Pacific, Latin America, and Middle East regions are seeing significant investments in the modernization of healthcare, laboratory automation, and the development of innovative devices. Governments and private healthcare providers are collaborating to enhance diagnostic capacity through public-private partnerships, the establishment of specialized respiratory testing centers, and the implementation of point-of-care testing. These efforts will lead to increased access to diagnostic services, shorter turnaround times, and enhanced disease management in both urban and rural areas.

In addition, government programs and international public health initiatives play a crucial role in supporting the global diagnostic ecosystem. Existing efforts by the WHO, the Global Fund, and the Ministries of Health of various countries to enhance surveillance of respiratory diseases, fund research, and provide equitable access to critical diagnostic supplies indicate that the global diagnostic community is working collaboratively to strengthen diagnostic capabilities worldwide and improve public health. Changes in reimbursement environments, public awareness campaigns, global strategic funding for innovations, and collaborative research efforts are reshaping global adherence to molecular and digital diagnostics. Overall, these aims aim to provide an ecosystem and ultimately improve public health by reducing the burden of acute respiratory disease through early, accurate, and accessible diagnostics.

Global Acute Respiratory Disease Diagnostics Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, the analyst has segmented the global acute respiratory disease diagnostics market based on test, pathogen, end-use, and region:

Test Outlook (Revenue, USD Million, 2021-2033)

  • Molecular Diagnostics
  • Antigen-based Rapid Tests
  • Serological Tests (IgM/IgG)
  • Syndromic Respiratory Panels
  • Other Emerging Technologies (CRISPR-based, Nanopore Sequencing, AI-driven Imaging)

Pathogen Outlook (Revenue, USD Million, 2021-2033)

  • Viral Infections
  • Bacterial Infections
  • Others

End-use Outlook (Revenue, USD Million, 2021-2033)

  • Hospitals & Clinics
  • Diagnostic and Reference Labs
  • Home Testing
  • Others (Public health, surveillance labs)

Regional Outlook (Revenue, USD Million, 2021-2033)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa (MEA)

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

This product will be delivered within 2 business days.

Table of Contents

Chapter 1. Acute Respiratory Disease Diagnostics Market: Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Segment Definitions
1.1.1.1. Test Method
1.1.1.2. Pathogen Segment
1.1.1.3. End Use Segment
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Objectives
1.4.1. Objective - 1
1.4.2. Objective - 2
1.4.3. Objective - 3
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. Internal Database
1.6.3. Secondary Sources
1.6.4. Primary Research
1.7. Information or Data Analysis
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.10. List of Secondary Sources
1.11. List of Abbreviations
Chapter 2. Acute Respiratory Disease Diagnostics Market: Executive Summary
2.1. Market Snapshot
2.2. Test Snapshot
2.3. Pathogen Snapshot
2.4. End Use Snapshot
2.5. Competitive Landscape Snapshot
Chapter 3. Acute Respiratory Disease Diagnostics Market Variables, Trends, & Scope
3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Dynamics
3.4. Market Drivers Analysis
3.4.1. Rising disease burden of respiratory conditions
3.4.2. Advancements in diagnostic technologies
3.4.3. Increasing demand for early detection and decentralised testing
3.5. Market Restraint Analysis
3.5.1. High cost of advanced diagnostics
3.5.2. Limited awareness and under-screening
3.5.3. Infrastructure & skilled workforce constraints
3.6. Porter’s Five Forces Analysis
3.7. PESTLE Analysis
3.8. Pipeline Analysis
Chapter 4. Acute Respiratory Disease Diagnostics Market: Test Estimates & Trend Analysis
4.1. Acute Respiratory Disease Diagnostics Market: Test Movement Analysis
4.2. Molecular Diagnostics
4.2.1. Market Estimates and Forecasts, 2021-2033 (USD Million)
4.2.2. PCR
4.2.2.1. Market Estimates and Forecasts, 2021-2033 (USD Million)
4.2.3. INAAT
4.2.3.1. Market Estimates and Forecasts, 2021-2033 (USD Million)
4.3. Antigen-based Rapid Tests
4.3.1. Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4. Serological Tests (IgM/IgG)
4.4.1. Market Estimates and Forecasts, 2021-2033 (USD Million)
4.5. Syndromic Respiratory Panels
4.5.1. Market Estimates and Forecasts, 2021-2033 (USD Million)
4.6. Other Emerging Technologies (CRISPR-based, Nanopore Sequencing, AI-driven Imaging)
4.6.1. Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 5. Acute Respiratory Disease Diagnostics Market: Pathogen Estimates & Trend Analysis
5.1. Acute Respiratory Disease Diagnostics Market: Pathogen Movement Analysis
5.2. Viral Infections
5.2.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.2.2. Influenza A & B
5.2.2.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.2.3. Respiratory Syncytial Virus (RSV)
5.2.3.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.2.4. SARS-CoV-2
5.2.4.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.2.5. Others
5.2.5.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.3. Bacterial Infections
5.3.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.3.2. Streptococcus pneumoniae
5.3.2.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.3.3. Haemophilus influenzae
5.3.3.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.3.4. Mycoplasma pneumoniae
5.3.4.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.3.5. Bordetella pertussis
5.3.5.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.4. Others
5.4.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 6. Acute Respiratory Disease Diagnostics Market: End Use Estimates & Trend Analysis
6.1. Acute Respiratory Disease Diagnostics Market: End Use Movement Analysis
6.2. Hospitals & Clinics
6.2.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
6.3. Diagnostic and Reference Labs
6.3.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
6.4. Home Testing
6.4.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
6.5. Others (Public health, surveillance labs)
6.5.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 7. Acute Respiratory Disease Diagnostics Market: Regional Business Analysis
7.1. Regional Market Snapshot
7.2. North America
7.2.1. North America Acute Respiratory Disease Diagnostics Market Estimates and Forecast, 2021-2033 (USD Million)
7.2.2. U.S.
7.2.2.1. U.S. Acute Respiratory Disease Diagnostics Market, 2021-2033 (USD Million)
7.2.2.2. Key Country Dynamics
7.2.2.3. Regulatory Framework
7.2.2.4. Reimbursement Scenario
7.2.2.5. Competitive Scenario
7.2.3. Canada
7.2.3.1. Canada Acute Respiratory Disease Diagnostics Market, 2021-2033 (USD Million)
7.2.3.2. Key Country Dynamics
7.2.3.3. Regulatory Framework
7.2.3.4. Reimbursement Scenario
7.2.3.5. Competitive Scenario
7.2.4. Mexico
7.2.4.1. Mexico Acute Respiratory Disease Diagnostics Market, 2021-2033 (USD Million)
7.2.4.2. Key Country Dynamics
7.2.4.3. Regulatory Framework
7.2.4.4. Reimbursement Scenario
7.2.4.5. Competitive Scenario
7.3. Europe
7.3.1. Europe Acute Respiratory Disease Diagnostics Market, 2021-2033 (USD Million)
7.3.2. UK
7.3.2.1. UK Acute Respiratory Disease Diagnostics Market, 2021-2033 (USD Million)
7.3.2.2. Key Country Dynamics
7.3.2.3. Regulatory Framework
7.3.2.4. Reimbursement Scenario
7.3.2.5. Competitive Scenario
7.3.3. Germany
7.3.3.1. Germany Acute Respiratory Disease Diagnostics Market, 2021-2033 (USD Million)
7.3.3.2. Key Country Dynamics
7.3.3.3. Regulatory Framework
7.3.3.4. Reimbursement Scenario
7.3.3.5. Competitive Scenario
7.3.4. Spain
7.3.4.1. Spain Acute Respiratory Disease Diagnostics Market, 2021-2033 (USD Million)
7.3.4.2. Key Country Dynamics
7.3.4.3. Regulatory Framework
7.3.4.4. Reimbursement Scenario
7.3.4.5. Competitive Scenario
7.3.5. France
7.3.5.1. France Acute Respiratory Disease Diagnostics Market, 2021-2033 (USD Million)
7.3.5.2. Key Country Dynamics
7.3.5.3. Regulatory Framework
7.3.5.4. Reimbursement Scenario
7.3.5.5. Competitive Scenario
7.3.6. Italy
7.3.6.1. Italy Acute Respiratory Disease Diagnostics Market, 2021-2033 (USD Million)
7.3.6.2. Key Country Dynamics
7.3.6.3. Regulatory Framework
7.3.6.4. Reimbursement Scenario
7.3.6.5. Competitive Scenario
7.3.7. Denmark
7.3.7.1. Denmark Acute Respiratory Disease Diagnostics Market, 2021-2033 (USD Million)
7.3.7.2. Key Country Dynamics
7.3.7.3. Regulatory Framework
7.3.7.4. Reimbursement Scenario
7.3.7.5. Competitive Scenario
7.3.8. Sweden
7.3.8.1. Sweden Acute Respiratory Disease Diagnostics Market, 2021-2033 (USD Million)
7.3.8.2. Key Country Dynamics
7.3.8.3. Regulatory Framework
7.3.8.4. Reimbursement Scenario
7.3.8.5. Competitive Scenario
7.3.9. Norway
7.3.9.1. Norway Acute Respiratory Disease Diagnostics Market, 2021-2033 (USD Million)
7.3.9.2. Key Country Dynamics
7.3.9.3. Regulatory Framework
7.3.9.4. Reimbursement Scenario
7.3.9.5. Competitive Scenario
7.4. Asia-Pacific
7.4.1. Asia-Pacific Acute Respiratory Disease Diagnostics Market, 2021-2033 (USD Million)
7.4.2. Japan
7.4.2.1. Japan Acute Respiratory Disease Diagnostics Market, 2021-2033 (USD Million)
7.4.2.2. Key Country Dynamics
7.4.2.3. Regulatory Framework
7.4.2.4. Reimbursement Scenario
7.4.2.5. Competitive Scenario
7.4.3. China
7.4.3.1. China Acute Respiratory Disease Diagnostics Market, 2021-2033 (USD Million)
7.4.3.2. Key Country Dynamics
7.4.3.3. Regulatory Framework
7.4.3.4. Reimbursement Scenario
7.4.3.5. Competitive Scenario
7.4.4. India
7.4.4.1. India Acute Respiratory Disease Diagnostics Market, 2021-2033 (USD Million)
7.4.4.2. Key Country Dynamics
7.4.4.3. Regulatory Framework
7.4.4.4. Reimbursement Scenario
7.4.4.5. Competitive Scenario
7.4.5. South Korea
7.4.5.1. South Korea Acute Respiratory Disease Diagnostics Market, 2021-2033 (USD Million)
7.4.5.2. Key Country Dynamics
7.4.5.3. Regulatory Framework
7.4.5.4. Reimbursement Scenario
7.4.5.5. Competitive Scenario
7.4.6. Thailand
7.4.6.1. Thailand Acute Respiratory Disease Diagnostics Market, 2021-2033 (USD Million)
7.4.6.2. Key Country Dynamics
7.4.6.3. Regulatory Framework
7.4.6.4. Reimbursement Scenario
7.4.6.5. Competitive Scenario
7.4.7. Australia
7.4.7.1. Australia Acute Respiratory Disease Diagnostics Market, 2021-2033 (USD Million)
7.4.7.2. Key Country Dynamics
7.4.7.3. Regulatory Framework
7.4.7.4. Reimbursement Scenario
7.4.7.5. Competitive Scenario
7.5. Latin America
7.5.1. Latin America Acute Respiratory Disease Diagnostics Market, 2021-2033 (USD Million)
7.5.2. Brazil
7.5.2.1. Brazil Acute Respiratory Disease Diagnostics Market, 2021-2033 (USD Million)
7.5.2.2. Key Country Dynamics
7.5.2.3. Regulatory Framework
7.5.2.4. Reimbursement Scenario
7.5.2.5. Competitive Scenario
7.5.3. Argentina
7.5.3.1. Argentina Acute Respiratory Disease Diagnostics Market, 2021-2033 (USD Million)
7.5.3.2. Key Country Dynamics
7.5.3.3. Regulatory Framework
7.5.3.4. Reimbursement Scenario
7.5.3.5. Competitive Scenario
7.6. MEA
7.6.1. MEA Acute Respiratory Disease Diagnostics Market, 2021-2033 (USD Million)
7.6.2. South Africa
7.6.2.1. South Africa Acute Respiratory Disease Diagnostics Market, 2021-2033 (USD Million)
7.6.2.2. Key Country Dynamics
7.6.2.3. Regulatory Framework
7.6.2.4. Reimbursement Scenario
7.6.2.5. Competitive Scenario
7.6.3. Saudi Arabia
7.6.3.1. Saudi Arabia Acute Respiratory Disease Diagnostics Market, 2021-2033 (USD Million)
7.6.3.2. Key Country Dynamics
7.6.3.3. Regulatory Framework
7.6.3.4. Reimbursement Scenario
7.6.3.5. Competitive Scenario
7.6.4. UAE
7.6.4.1. UAE Acute Respiratory Disease Diagnostics Market, 2021-2033 (USD Million)
7.6.4.2. Key Country Dynamics
7.6.4.3. Regulatory Framework
7.6.4.4. Reimbursement Scenario
7.6.4.5. Competitive Scenario
7.6.5. Kuwait
7.6.5.1. Kuwait Acute Respiratory Disease Diagnostics Market, 2021-2033 (USD Million)
7.6.5.2. Key Country Dynamics
7.6.5.3. Regulatory Framework
7.6.5.4. Reimbursement Scenario
7.6.5.5. Competitive Scenario
Chapter 8. Competitive Landscape
8.1. Company Categorization
8.2. Strategy Mapping
8.2.1. New Product Launch
8.2.2. Partnerships
8.2.3. Acquisition
8.2.4. Collaboration
8.2.5. Funding
8.3. Key Company Market Share Analysis, 2024
8.4. Company Heat Map Analysis
8.5. Company Profiles
8.5.1. F. Hoffmann La-Roche
8.5.1.1. Overview
8.5.1.2. Financial Performance
8.5.1.3. Product Benchmarking
8.5.1.4. Strategic Initiatives
8.5.2. Abbott Laboratories
8.5.2.1. Overview
8.5.2.2. Financial Performance
8.5.2.3. Product Benchmarking
8.5.2.4. Strategic Initiatives
8.5.3. Quidel Corporation
8.5.3.1. Overview
8.5.3.2. Financial Performance
8.5.3.3. Product Benchmarking
8.5.3.4. Strategic Initiatives
8.5.4. Becton, Dickinson and Company (BD)
8.5.4.1. Overview
8.5.4.2. Financial Performance
8.5.4.3. Product Benchmarking
8.5.4.4. Strategic Initiatives
8.5.5. Thermo Fisher Scientific, Inc.
8.5.5.1. Overview
8.5.5.2. Financial Performance
8.5.5.3. Product Benchmarking
8.5.5.4. Strategic Initiatives
8.5.6. Siemens Healthineers
8.5.6.1. Overview
8.5.6.2. Financial Performance
8.5.6.3. Product Benchmarking
8.5.6.4. Strategic Initiatives
8.5.7. Bio-Rad Laboratories
8.5.7.1. Overview
8.5.7.2. Financial Performance
8.5.7.3. Product Benchmarking
8.5.7.4. Strategic Initiatives
8.5.8. Luminex Corporation
8.5.8.1. Overview
8.5.8.2. Financial Performance
8.5.8.3. Product Benchmarking
8.5.8.4. Strategic Initiatives
8.5.9. BioMérieux
8.5.9.1. Overview
8.5.9.2. Financial Performance
8.5.9.3. Product Benchmarking
8.5.9.4. Strategic Initiatives
8.5.10. Meridian Bioscience
8.5.10.1. Overview
8.5.10.2. Financial Performance
8.5.10.3. Product Benchmarking
8.5.10.4. Strategic Initiatives
8.5.11. Fujirebio Diagnostics
8.5.11.1. Overview
8.5.11.2. Financial Performance
8.5.11.3. Product Benchmarking
8.5.11.4. Strategic Initiatives
8.5.12. Cepheid
8.5.12.1. Overview
8.5.12.2. Financial Performance
8.5.12.3. Product Benchmarking
8.5.12.4. Strategic Initiatives
8.5.13. Lumos Diagnostics
8.5.13.1. Overview
8.5.13.2. Financial Performance
8.5.13.3. Product Benchmarking
8.5.13.4. Strategic Initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviation
Table 3 Global Acute Respiratory Disease Diagnostics Market, By Region, 2021-2033 (USD Million)
Table 4 Global Acute Respiratory Disease Diagnostics Market, By Test, 2021-2033 (USD Million)
Table 5 Global Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021-2033 (USD Million)
Table 6 Global Acute Respiratory Disease Diagnostics Market, By End Use, 2021-2033 (USD Million)
Table 7 North America Acute Respiratory Disease Diagnostics Market, By Country, 2021-2033 (USD Million)
Table 8 North America Acute Respiratory Disease Diagnostics Market, By Test, 2021-2033 (USD Million)
Table 9 North America Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021-2033 (USD Million)
Table 10 North America Acute Respiratory Disease Diagnostics Market, By End Use, 2021-2033 (USD Million)
Table 11 U.S. Acute Respiratory Disease Diagnostics Market, By Test, 2021-2033 (USD Million)
Table 12 U.S. Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021-2033 (USD Million)
Table 13 U.S. Acute Respiratory Disease Diagnostics Market, By End Use, 2021-2033 (USD Million)
Table 14 Canada Acute Respiratory Disease Diagnostics Market, By Test, 2021-2033 (USD Million)
Table 15 Canada Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021-2033 (USD Million)
Table 16 Canada Acute Respiratory Disease Diagnostics Market, By End Use, 2021-2033 (USD Million)
Table 17 Mexico Acute Respiratory Disease Diagnostics Market, By Test, 2021-2033 (USD Million)
Table 18 Mexico Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021-2033 (USD Million)
Table 19 Mexico Acute Respiratory Disease Diagnostics Market, By End Use, 2021-2033 (USD Million)
Table 20 Europe Acute Respiratory Disease Diagnostics Market, By Country, 2021-2033 (USD Million)
Table 21 Europe Acute Respiratory Disease Diagnostics Market, By Test, 2021-2033 (USD Million)
Table 22 Europe Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021-2033 (USD Million)
Table 23 Europe Acute Respiratory Disease Diagnostics Market, By End Use, 2021-2033 (USD Million)
Table 24 UK Acute Respiratory Disease Diagnostics Market, By Test, 2021-2033 (USD Million)
Table 25 UK Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021-2033 (USD Million)
Table 26 UK Acute Respiratory Disease Diagnostics Market, By End Use, 2021-2033 (USD Million)
Table 27 Germany Acute Respiratory Disease Diagnostics Market, By Test, 2021-2033 (USD Million)
Table 28 Germany Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021-2033 (USD Million)
Table 29 Germany Acute Respiratory Disease Diagnostics Market, By End Use, 2021-2033 (USD Million)
Table 30 France Acute Respiratory Disease Diagnostics Market, By Test, 2021-2033 (USD Million)
Table 31 France Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021-2033 (USD Million)
Table 32 France Acute Respiratory Disease Diagnostics Market, By End Use, 2021-2033 (USD Million)
Table 33 Italy Acute Respiratory Disease Diagnostics Market, By Test, 2021-2033 (USD Million)
Table 34 Italy Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021-2033 (USD Million)
Table 35 Italy Acute Respiratory Disease Diagnostics Market, By End Use, 2021-2033 (USD Million)
Table 36 Spain Acute Respiratory Disease Diagnostics Market, By Test, 2021-2033 (USD Million)
Table 37 Spain Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021-2033 (USD Million)
Table 38 Spain Acute Respiratory Disease Diagnostics Market, By End Use, 2021-2033 (USD Million)
Table 39 Denmark Acute Respiratory Disease Diagnostics Market, By Test, 2021-2033 (USD Million)
Table 40 Denmark Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021-2033 (USD Million)
Table 41 Denmark Acute Respiratory Disease Diagnostics Market, By End Use, 2021-2033 (USD Million)
Table 42 Sweden Acute Respiratory Disease Diagnostics Market, By Test, 2021-2033 (USD Million)
Table 43 Sweden Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021-2033 (USD Million)
Table 44 Sweden Acute Respiratory Disease Diagnostics Market, By End Use, 2021-2033 (USD Million)
Table 45 Norway Acute Respiratory Disease Diagnostics Market, By Test, 2021-2033 (USD Million)
Table 46 Norway Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021-2033 (USD Million)
Table 47 Norway Acute Respiratory Disease Diagnostics Market, By End Use, 2021-2033 (USD Million)
Table 48 Asia-Pacific Acute Respiratory Disease Diagnostics Market, By Country, 2021-2033 (USD Million)
Table 49 Asia-Pacific Acute Respiratory Disease Diagnostics Market, By Test, 2021-2033 (USD Million)
Table 50 Asia-Pacific Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021-2033 (USD Million)
Table 51 Asia-Pacific Acute Respiratory Disease Diagnostics Market, By End Use, 2021-2033 (USD Million)
Table 52 Japan Acute Respiratory Disease Diagnostics Market, By Test, 2021-2033 (USD Million)
Table 53 Japan Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021-2033 (USD Million)
Table 54 Japan Acute Respiratory Disease Diagnostics Market, By End Use, 2021-2033 (USD Million)
Table 55 China Acute Respiratory Disease Diagnostics Market, By Test, 2021-2033 (USD Million)
Table 56 China Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021-2033 (USD Million)
Table 57 China Acute Respiratory Disease Diagnostics Market, By End Use, 2021-2033 (USD Million)
Table 58 India Acute Respiratory Disease Diagnostics Market, By Test, 2021-2033 (USD Million)
Table 59 India Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021-2033 (USD Million)
Table 60 India Acute Respiratory Disease Diagnostics Market, By End Use, 2021-2033 (USD Million)
Table 61 Australia Acute Respiratory Disease Diagnostics Market, By Test, 2021-2033 (USD Million)
Table 62 Australia Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021-2033 (USD Million)
Table 63 Australia Acute Respiratory Disease Diagnostics Market, By End Use, 2021-2033 (USD Million)
Table 64 South Korea Acute Respiratory Disease Diagnostics Market, By Test, 2021-2033 (USD Million)
Table 65 South Korea Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021-2033 (USD Million)
Table 66 South Korea Acute Respiratory Disease Diagnostics Market, By End Use, 2021-2033 (USD Million)
Table 67 Thailand Acute Respiratory Disease Diagnostics Market, By Test, 2021-2033 (USD Million)
Table 68 Thailand Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021-2033 (USD Million)
Table 69 Thailand Acute Respiratory Disease Diagnostics Market, By End Use, 2021-2033 (USD Million)
Table 70 Latin America Acute Respiratory Disease Diagnostics Market, By Country, 2021-2033 (USD Million)
Table 71 Latin America Acute Respiratory Disease Diagnostics Market, By Test, 2021-2033 (USD Million)
Table 72 Latin America Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021-2033 (USD Million)
Table 73 Latin America Acute Respiratory Disease Diagnostics Market, By End Use, 2021-2033 (USD Million)
Table 74 Brazil Acute Respiratory Disease Diagnostics Market, By Test, 2021-2033 (USD Million)
Table 75 Brazil Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021-2033 (USD Million)
Table 76 Brazil Acute Respiratory Disease Diagnostics Market, By End Use, 2021-2033 (USD Million)
Table 77 Argentina Acute Respiratory Disease Diagnostics Market, By Test, 2021-2033 (USD Million)
Table 78 Argentina Acute Respiratory Disease Diagnostics Market, By End Use, 2021-2033 (USD Million)
Table 79 MEA Acute Respiratory Disease Diagnostics Market, By Country, 2021-2033 (USD Million)
Table 80 MEA Acute Respiratory Disease Diagnostics Market, By Test, 2021-2033 (USD Million)
Table 81 MEA Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021-2033 (USD Million)
Table 82 MEA Acute Respiratory Disease Diagnostics Market, By End Use, 2021-2033 (USD Million)
Table 83 South Africa Acute Respiratory Disease Diagnostics Market, By Test, 2021-2033 (USD Million)
Table 84 South Africa Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021-2033 (USD Million)
Table 85 South Africa Acute Respiratory Disease Diagnostics Market, By End Use, 2021-2033 (USD Million)
Table 86 Saudi Arabia Acute Respiratory Disease Diagnostics Market, By Test, 2021-2033 (USD Million)
Table 87 Saudi Arabia Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021-2033 (USD Million)
Table 88 Saudi Arabia Acute Respiratory Disease Diagnostics Market, By End Use, 2021-2033 (USD Million)
Table 89 UAE Acute Respiratory Disease Diagnostics Market, By Test, 2021-2033 (USD Million)
Table 90 UAE Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021-2033 (USD Million)
Table 91 UAE Acute Respiratory Disease Diagnostics Market, By End Use, 2021-2033 (USD Million)
Table 92 Kuwait Acute Respiratory Disease Diagnostics Market, By Test, 2021-2033 (USD Million)
Table 93 Kuwait Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021-2033 (USD Million)
Table 94 Kuwait Acute Respiratory Disease Diagnostics Market, By End Use, 2021-2033 (USD Million)
List of Figures
Figure 1 Acute Respiratory Disease Diagnostics Market segmentation
Figure 2 Market research process
Figure 3 Data triangulation techniques
Figure 4 Primary research pattern
Figure 5 Market research approaches
Figure 6 Value-chain-based sizing & forecasting
Figure 7 QFD modelling for market share assessment.
Figure 8 Market formulation & validation
Figure 9 Acute Respiratory Disease Diagnostics Market snapshot
Figure 10 Parent market outlook
Figure 11 Related/ancillary market outlook.
Figure 12 Penetration and growth prospect mapping
Figure 13 Acute Respiratory Disease Diagnostics Market driver impact
Figure 14 Acute Respiratory Disease Diagnostics Market restraint impact
Figure 15 SWOT analysis, by factor (political & legal, economic, and technological)
Figure 16 Industry Analysis - Porter's
Figure 17 Strategy mapping
Figure 18 Acute Respiratory Disease Diagnostics Market: Test outlook and key takeaways
Figure 19 Acute Respiratory Disease Diagnostics Market: Test movement analysis & market share 2024 & 2033
Figure 20 Molecular Diagnostics Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 21 PCR Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 22 INAAT Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 23 Antigen-based Rapid Tests Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 24 Serological Tests (IgM/IgG) Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 25 Syndromic Respiratory Panels Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 26 Other Emerging Technologies (CRISPR-based, Nanopore Sequencing, AI-driven Imaging) Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 27 Acute Respiratory Disease Diagnostics Market: Pathogen outlook and key takeaways
Figure 28 Acute Respiratory Disease Diagnostics Market: Pathogen movement analysis & market share 2024 & 2033
Figure 29 Viral Infections Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 30 Influenza A & B Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 31 Respiratory Syncytial Virus (RSV) Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 32 SARS-CoV-2 Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 33 Others Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 34 Bacterial Infections Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 35 Streptococcus Pneumoniae Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 36 Haemophilus influenzae Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 37 Mycoplasma pneumoniae Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 38 Bordetella pertussis Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 39 Others Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 40 Acute Respiratory Disease Diagnostics Market: End Use outlook and key takeaways
Figure 41 Acute Respiratory Disease Diagnostics Market: End Use movement analysis & market share 2024 & 2033
Figure 42 Hospitals & Clinics Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 43 Diagnostic and Reference Labs Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 44 Home Testing Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 45 Others (Public health, surveillance labs) Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 46 Regional marketplace: Key takeaways
Figure 47 Global Acute Respiratory Disease Diagnostics Market: Regional movement analysis
Figure 48 U.S. Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 49 Canada Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 50 Mexico Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 51 Europe Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 52 UK Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 53 Germany Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 54 France Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 55 Italy Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 56 Spain Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 57 Denmark Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 58 Sweden Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 59 Norway Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 60 Asia-Pacific Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 61 Japan Market Estimates and Forecast, 2021-2033(USD Million)
Figure 62 China Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 63 India Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 64 South Korea Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 65 Australia Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 66 Thailand Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 67 Latin America Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 68 Brazil Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 69 Argentina Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 70 MEA Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 71 South Africa Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 72 Saudi Arabia Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 73 UAE Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 74 Kuwait Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 75 Strategy framework

Companies Mentioned

The key companies profiled in this Acute Respiratory Disease Diagnostics market report include:
  • F. Hoffmann La-Roche
  • Abbott Laboratories
  • Quidel Corporation
  • Becton, Dickinson and Company (BD)
  • Thermo Fisher Scientific, Inc.
  • Siemens Healthineers
  • Bio-Rad Laboratories
  • Luminex Corporation
  • BioMérieux
  • Meridian Bioscience
  • Fujirebio Diagnostics
  • Cepheid
  • Lumos Diagnostics

Table Information

Report AttributeDetails
No. of Pages150
PublishedNovember 2025
Forecast Period2024 - 2033
Estimated Market Value ( USD ) in 2024 $ 5.49 Billion
Forecasted Market Value ( USD ) by 2033 $ 10.71 Billion
Compound Annual Growth Rate7.0%
Regions CoveredGlobal
No. of Companies Mentioned14

Related Topics

Related Reports

Acute Care Syndromic Testing Market - A Global and Regional Analysis: Focus on Disease Type, Target, Sample Type, End User and Country Analysis - Analysis and Forecast, 2023-2033 - Product Image

Acute Care Syndromic Testing Market - A Global and Regional Analysis: Focus on Disease Type, Target, Sample Type, End User and Country Analysis - Analysis and Forecast, 2023-2033

  • Report
  • 227 Pages
  • Global
From
Rapid Pathogen Detection Diagnostics Market Size, Share & Trends Analysis Report by Product (Instruments, Rapid Test Kits, Consumables & Reagents), Technology (Immunoassays, NAAT), Application, End-use and Region with Growth Forecasts, 2025-2033 - Product Image

Rapid Pathogen Detection Diagnostics Market Size, Share & Trends Analysis Report by Product (Instruments, Rapid Test Kits, Consumables & Reagents), Technology (Immunoassays, NAAT), Application, End-use and Region with Growth Forecasts, 2025-2033

  • Report
  • 130 Pages
  • Global
From
Europe Acute Care Syndromic Testing Market - Analysis and Forecast, 2023-2033 - Product Image

Europe Acute Care Syndromic Testing Market - Analysis and Forecast, 2023-2033

  • Report
  • 110 Pages
  • Europe
From
Asia-Pacific Acute Care Syndromic Testing Market: Analysis and Forecast, 2023-2033 - Product Image

Asia-Pacific Acute Care Syndromic Testing Market: Analysis and Forecast, 2023-2033

  • Report
  • 93 Pages
  • Asia Pacific
From
Respiratory Diagnostics Market 2025-2033 - Product Image

Respiratory Diagnostics Market 2025-2033

  • Report
  • 135 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.